XML 66 R56.htm IDEA: XBRL DOCUMENT v3.26.1
Business Segment: (Details)
3 Months Ended
Mar. 31, 2026
USD ($)
segment
Mar. 31, 2025
USD ($)
Business Segment:    
Number of operating segments | segment 1  
Number of reportable segments | segment 1  
Total research and development expenses $ 28,600 $ 60,816
Single business segment    
Business Segment:    
External clinical development expenses 10,352 26,191
Personnel related and stock-based compensation 2,512 12,825
Other research and development expenses 15,736 21,800
Total research and development expenses $ 28,600 $ 60,816